(85) found that CRAF overexpression to increased ERK1/2 level indicating some BRAF mutant tumor cells were primary insensitive to RAF inhibition in the experiment, which was related to a switch from BRAF to CRAF dependency in tumor cells. The gene discussed is RAF1; the disease is neoplasm.